デフォルト表紙
市場調査レポート
商品コード
1439314

血管閉鎖デバイス - 世界市場の考察、競合情勢、市場予測(2030年)

Vascular Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.36円
血管閉鎖デバイス - 世界市場の考察、競合情勢、市場予測(2030年)
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血管閉鎖デバイスの市場規模は、2023年に11億1,000万米ドル、2030年までに15億9,000万米ドルに達し、2024年~2030年の予測期間にCAGRで6.18%の成長が見込まれます。心筋梗塞などの心血管疾患の有病率の増加、肥満や高血圧などの心血管疾患に関連する危険因子の有病率の上昇、老年人口の増加、低侵襲手技の人気の急上昇などの要因が、血管閉鎖デバイス市場を牽引すると予測されています。

血管閉鎖デバイスの市場力学

血管閉鎖デバイス市場は、世界の心血管疾患の有病率の上昇により、需要の増加を示しています。世界保健機関(WHO)(2023)が提供したデータによると、心血管疾患(CVDs)は世界中での主な死因であり、毎年推定1,790万人の命を奪っています。さらに、WHOの同データによると、心血管疾患に関連する死亡の5件中4件以上が脳卒中と心臓発作を主因としており、これらの死亡の3分の1は70歳未満で早期に発生すると推定されています。

欧州心臓病学会(ESC)(2023)のデータによると、毎年、欧州では心血管疾患(CVD)が390万人の死因となっており、欧州連合(EU)では180万人以上が死亡しています。欧州では全死亡の約45%、欧州連合では37%を占めています。

一般的な心血管疾患には、冠動脈性心疾患、脳卒中、末梢性心疾患、心不全などがあります。

さらに、座りがちなライフスタイルなどの不健康な生活習慣が、あらゆる年齢層で肥満の有病率の増加をもたらしています。世界保健機関(WHO)が発表した肥満に関するファクトシート(2023)によると、18歳以上の成人19億人以上が過体重であり、そのうち6億5,000万人が肥満でした。肥満は心血管疾患発症の主な危険因子の1つと考えられています。肥満度が上昇すると血圧が上昇し、心血管疾患の罹患率が高まると考えられています。

したがって、心血管疾患の有病率の増加と関連する危険因子は、血管造影や血管形成術のような診断と治療の両方の目的のためのインターベンショナル心臓手技の需要の伸びにつながっています。そのため、血管閉鎖デバイスは時間効率のよい方法でアクセス部位を封止するのに役立つため、ニーズが増加しています。

さらに、新たな開発などの低侵襲手技の人気の高まりが、VCDの利用を促進し続けています。現在の動向では、大口径の大腿動脈の切開を安全かつ効率的に閉鎖できるデバイスの開発に焦点が当てられています。経カテーテル大動脈弁修復術や経皮的血管内動脈瘤修復術が一般的になるにつれて、単純ながら効果的なVCDを開発し、その有用性を証明する大きな動機が生まれます。

しかし、血管閉鎖デバイスに伴う合併症や大口径の穿刺の閉鎖における血管閉鎖デバイスの限界が、血管閉鎖デバイス市場の成長に対する一定の抑制要因となる可能性があります。

血管閉鎖デバイス市場のセグメント分析

血管閉鎖デバイス市場の製品セグメントでは、血管デバイスの動的近似器カテゴリが血管閉鎖デバイス市場で大きな収益シェアを獲得すると予測されています。これは、血流を止めるのに時間がかかる静的近似器と比較して、即時の血管閉鎖を提供するという点で、静的近似器よりも優れた品質であることに起因しています。動的近似器はさらに縫合ベース、クリップベース、圧迫補助デバイスにセグメンテーションされます。

さらに、静的近似器カテゴリは、生体材料ベースのデバイスの人気の高まりにより、予測期間に血管閉鎖デバイスでより速い成長を示すと予測されています。

北米が血管閉鎖デバイス市場全体を独占すると予測されます。

全地域の中で、北米が血管閉鎖デバイス市場で大きな市場シェアを占めると予測されています。北米が圧倒的な市場シェアを占めると予測されるのは、心血管疾患とそれに関連する危険因子の高い有病率、老年人口の増加、疾病管理に関する人々の高い意識、こうしたデバイスを購入する能力などのためです。

当レポートでは、世界の血管閉鎖デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 血管閉鎖デバイス市場レポートのイントロダクション

第2章 血管閉鎖デバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
  • 日本

第4章 血管閉鎖デバイス市場の主な要因の分析

  • 血管閉鎖デバイス市場の促進要因
    • 心血管疾患の増加
    • CVDに関連する危険因子の有病率の増加
    • 低侵襲手術の人気の高まり
    • 製品イノベーション活動の急増
  • 血管閉鎖デバイス市場の抑制要因と課題
    • 血管閉鎖デバイスに関連する合併症
    • 大口径の穿刺の閉鎖における血管閉鎖デバイスの限界
  • 血管閉鎖デバイス市場の機会
    • 生体吸収性血管閉鎖デバイスの開発

第5章 血管閉鎖デバイス市場のポーターのファイブフォース分析

第6章 血管閉鎖デバイス市場に対するCOVID-19の影響分析

第7章 血管閉鎖デバイス市場のレイアウト

  • 製品タイプ別
    • 動的近似器
    • 静的近似器
    • その他
  • アクセスタイプ別
    • 大腿
    • 橈骨
  • エンドユーザー別
    • 病院
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 血管閉鎖デバイス市場:世界の企業シェア分析 - 主要3~5社

第9章 血管閉鎖デバイス市場の企業と製品のプロファイル

  • Abbott
  • Teleflex Incorporated
  • Terumo Medical Corporation
  • Medtronic
  • Cardinal Health
  • Cardival Medical, Inc
  • Merit Medical systems
  • Morris Innovative
  • TZ Medical
  • Vasorum Ltd
  • Tricol Biomedical
  • Vivasure Medical Ltd.
  • Transluminal Technologies
  • W. L. Gore & Associates, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Gem srl

第10章 プロジェクトのアプローチ

  • 二次資料
  • 一次資料
  • データの三角測量
  • 主な専門家の意見

第11章 KOLの見解

第12章 DelveInsightのサービス内容

第13章 免責事項

第14章 DelveInsightについて

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Vascular Closure Devices Market
  • Table 3: Vascular Closure Devices Market in Global (2021-2030)
  • Table 4: Vascular Closure Devices Market in Global by Product Type (2021-2030)
  • Table 5: Vascular Closure Devices Market in Global by Access Type (2021-2030)
  • Table 6: Vascular Closure Devices Market in Global by End User (2021-2030)
  • Table 7: Vascular Closure Devices Market in Global by Geography (2021-2030)
  • Table 8: Vascular Closure Devices Market in North America (2021-2030)
  • Table 9: Vascular Closure Devices Market in North America by Product Type (2021-2030)
  • Table 10: Vascular Closure Devices Market in North America by Access Type (2021-2030)
  • Table 11: Vascular Closure Devices Market in North America by End User (2021-2030)
  • Table 12: Vascular Closure Devices Market in North America by Country (2021-2030)
  • Table 13: Vascular Closure Devices Market in the US (2021-2030)
  • Table 14: Vascular Closure Devices Market in Canada (2021-2030)
  • Table 15: Vascular Closure Devices Market in Mexico (2021-2030)
  • Table 16: Vascular Closure Devices Market in Europe (2021-2030)
  • Table 17: Vascular Closure Devices Market in Europe by Product Type (2021-2030)
  • Table 18: Vascular Closure Devices Market in Europe by Access Type (2021-2030)
  • Table 19: Vascular Closure Devices Market in Europe by End User (2021-2030)
  • Table 20: Vascular Closure Devices Market in Europe by Country (2021-2030)
  • Table 21: Vascular Closure Devices Market in France (2021-2030)
  • Table 22: Vascular Closure Devices Market in Germany (2021-2030)
  • Table 23: Vascular Closure Devices Market in the United Kingdom (2021-2030)
  • Table 24: Vascular Closure Devices Market in Italy (2021-2030)
  • Table 25: Vascular Closure Devices Market in Spain (2021-2030)
  • Table 26: Vascular Closure Devices Market in Russia (2021-2030)
  • Table 27: Vascular Closure Devices Market in Rest of Europe (2021-2030)
  • Table 28: Vascular Closure Devices Market in APAC (2021-2030)
  • Table 29: Vascular Closure Devices Market in APAC by Product Type (2021-2030)
  • Table 30: Vascular Closure Devices Market in APAC by Access Type (2021-2030)
  • Table 31: Vascular Closure Devices Market in APAC by End User (2021-2030)
  • Table 32: Vascular Closure Devices Market in APAC by Country (2021-2030)
  • Table 33: Vascular Closure Devices Market in China (2021-2030)
  • Table 34: Vascular Closure Devices Market in Japan (2021-2030)
  • Table 35: Vascular Closure Devices Market in India (2021-2030)
  • Table 36: Vascular Closure Devices Market in Australia (2021-2030)
  • Table 37: Vascular Closure Devices Market in South Korea (2021-2030)
  • Table 38: Vascular Closure Devices Market in Rest of APAC (2021-2030)
  • Table 39: Vascular Closure Devices Market in Rest of World (2021-2030)
  • Table 40: Vascular Closure Devices Market in RoW by Product Type (2021-2030)
  • Table 41: Vascular Closure Devices Market in RoW by Access Type (2021-2030)
  • Table 42: Vascular Closure Devices Market in RoW by End User (2021-2030)
  • Table 43: Vascular Closure Devices Market in RoW by Region (2021-2030)
  • Table 44: Vascular Closure Devices Market in Middle East (2021-2030)
  • Table 45: Vascular Closure Devices Market in Africa (2021-2030)
  • Table 46: Vascular Closure Devices Market in South America (2021-2030)

List of Figures

Figures 1: Competitive Analysis

Figures 2: COVID-19 Impact Analysis on Vascular Closure Devices Market

Figures 3: Vascular Closure Devices Market in Global (2021-2030)

Figures 4: Vascular Closure Devices Market in Global by Product Type (2021-2030)

Figures 5: Vascular Closure Devices Market in Global by Access Type (2021-2030)

Figures 6: Vascular Closure Devices Market in Global by End User (2021-2030)

Figures 7: Vascular Closure Devices Market in Global by Geography (2021-2030)

Figures 8: Vascular Closure Devices Market in North America (2021-2030)

Figures 9: Vascular Closure Devices Market in North America by Product Type (2021-2030)

Figures 10: Vascular Closure Devices Market in North America by Access Type (2021-2030)

Figures 11: Vascular Closure Devices Market in North America by End User (2021-2030)

Figures 12: Vascular Closure Devices Market in North America by Country (2021-2030)

Figures 13: Vascular Closure Devices Market in the US (2021-2030)

Figures 14: Vascular Closure Devices Market in Canada (2021-2030)

Figures 15: Vascular Closure Devices Market in Mexico (2021-2030)

Figures 16: Vascular Closure Devices Market in Europe (2021-2030)

Figures 17: Vascular Closure Devices Market in Europe by Product Type (2021-2030)

Figures 18: Vascular Closure Devices Market in Europe by Access Type (2021-2030)

Figures 19: Vascular Closure Devices Market in Europe by End User (2021-2030)

Figures 20: Vascular Closure Devices Market in Europe by Country (2021-2030)

Figures 21: Vascular Closure Devices Market in France (2021-2030)

Figures 22: Vascular Closure Devices Market in Germany (2021-2030)

Figures 23: Vascular Closure Devices Market in the United Kingdom (2021-2030)

Figures 24: Vascular Closure Devices Market in Italy (2021-2030)

Figures 25: Vascular Closure Devices Market in Spain (2021-2030)

Figures 26: Vascular Closure Devices Market in Russia (2021-2030)

Figures 27: Vascular Closure Devices Market in Rest of Europe (2021-2030)

Figures 28: Vascular Closure Devices Market in APAC (2021-2030)

Figures 29: Vascular Closure Devices Market in APAC by Product Type (2021-2030)

Figures 30: Vascular Closure Devices Market in APAC by Access Type (2021-2030)

Figures 31: Vascular Closure Devices Market in APAC by End User (2021-2030)

Figures 32: Vascular Closure Devices Market in APAC by Country (2021-2030)

Figures 33: Vascular Closure Devices Market in China (2021-2030)

Figures 34: Vascular Closure Devices Market in Japan (2021-2030)

Figures 35: Vascular Closure Devices Market in India (2021-2030)

Figures 36: Vascular Closure Devices Market in Australia (2021-2030)

Figures 37: Vascular Closure Devices Market in South Korea (2021-2030)

Figures 38: Vascular Closure Devices Market in Rest of APAC (2021-2030)

Figures 39: Vascular Closure Devices Market in Rest of World (2021-2030)

Figures 40: Vascular Closure Devices Market in RoW by Product Type (2021-2030)

Figures 41: Vascular Closure Devices Market in RoW by Access Type (2021-2030)

Figures 42: Vascular Closure Devices Market in RoW by End User (2021-2030)

Figures 43: Vascular Closure Devices Market in RoW by Region (2021-2030)

Figures 44: Vascular Closure Devices Market in Middle East (2021-2030)

Figures 45: Vascular Closure Devices Market in Africa (2021-2030)

Figures 46: Vascular Closure Devices Market in South America (2021-2030)

Figures 47: Market Drivers

Figures 48: Market Barriers

Figures 49: Marker Opportunities

Figures 50: PORTER'S Five Force Analysis

目次
Product Code: DIMDCL0106

Vascular Closure Devices Market By Product Type (Active Approximators [Suture-Based, Clip-Based, and Assisted Compression Devices] and Passive Approximators [Sealant-Or-Gel-Based And Bioabsorbable Plugs], and Others), By Access (Femoral And Radial), and By End User (Hospitals & Clinics, Ambulatory Surgical Centers, ad Others), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of cardiovascular diseases such as heart strokes and increasing prevalence of obesity.

Global Vascular Closure Devices Market was valued at USD 1.11 billion in 2023, growing at a CAGR of 6.18% during the forecast period from 2024 to 2030 to reach USD 1.59 billion by 2030. Factors such as the growing prevalence of cardiovascular disorders such as heart strokes, rising prevalence of risk factors associated with the cardiovascular diseases such as obesity and hypertension, increasing geriatric population, and the surge in the popularity of minimally invasive procedures, are expected to drive the vascular closure devices market.

Vascular Closure Devices Market Dynamics:

The vascular closure devices market is witnessing an increase in demand due to the rising prevalence of cardiovascular diseases the globe. As per the data provided by the World Health Organization (2023), cardiovascular diseases (CVDs) are the leading cause of death across the globe, accounting for an estimated 17.9 million loss of lives each year. Furthermore, the same data by the WHO presented that over four out of five deaths related to cardiovascular diseases list strokes and heart attacks as the main cause, and one-third of these deaths are estimate to occur prematurely in people below 70 years of age.

According to the data provided by the European Society for Cardiology (ESC) (2023), each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the European Union.

Some of the common cardiovascular diseases include coronary heart disease, strokes, peripheral heart disease, and heart failure among others.

Furthermore, the unhealthy lifestyle such as sedentary lifestyle has led to the increased prevalence of obesity in the world across all age groups. According to the factsheet provided by the World Health Organization on Obesity (2023), over 1.9 billion adults in the age group of 18 and above were overweight, out of which 650 million people were obese. Obesity is considered as one of the major risk factors for the development of cardiovascular diseases. It has been observed that the increase body mass index results in the increase in blood pressures and rates of cardiovascular diseases.

Therefore, the increase in the prevalence of cardiovascular diseases and the associated risk factors have led to the growth in demand for interventional cardiac procedures for both diagnostic and treatment purposes such as angiography and angioplasty. Therefore, the need for vascular closure devices is witnessing an increase as they help in the sealing of the access site in a time-efficient manner.

Moreover, the rising popularity of minimally invasive procedures such as new developments continue to advance the utilization of VCDs. Current trends are focused on developing devices that can safely and efficiently close large-caliber femoral arteriotomies. As trans-catheter aortic valve repair and percutaneous endovascular aneurysm repair become commonplace, there will be tremendous incentive to develop and prove the utility of a simple but effective VCD.

However, complications associated with the vascular closure devices, and limitations of vascular closure devices in closing large bore punctures may prove to be certain restraints to the vascular closures devices market growth.

Vascular Closure Devices Market Segment Analysis:

Vascular Closure Devices Market by Product Type (Active Approximators [Suture-Based, Clip-Based, and Assisted Compression Devices] and Passive Approximators [Sealant-Or-Gel-Based and Bioabsorbable Plugs], and Others), by Access (Femoral And Radial), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the vascular closure devices market, the active approximators category of the vascular devices is expected to amass the significant revenue share in the vascular closure devices market. This can be attributed to their advantageous quality over passive approximators in terms of providing immediate vascular closure compared to passive approximators that take time in ceasing the blood flow. The active approximators are further segmented into suture-based, clip-based, and compression-assist devices.

Furthermore, the passive approximators category is predicted to witness a faster growth in the vascular closure devices in the forecast period due to the growing popularity of the biomaterial-based devices.

North America is expected to dominate in the overall Vascular Closure Devices Market:

Among all the regions, North America is expected to account for the significant market share in the vascular closure devices market. North America is predicted to account for the dominant market share because of the high prevalence of cardiovascular diseases and associated risk factors, rising population of the elderly, high awareness among people regarding disease management and ability to afford such devices and among other factors in the region.

Heart diseases in an umbrella term which encompasses numerous indications such as acute coronary syndrome, atherosclerosis, congestive heart failure among others. As per the information provided by the Centers for Disease Control and Prevention (2023), some of the key risk factors associated with heart diseases are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.

Furthermore, as per the data provided by the Canadian Institute for Health Information, in 2020, about 2.4 million Canadians suffered from heart disease and was considered to be the second leading cause of death in the country. Therefore, this may result in an increase in the patient population suffering from heart diseases which may in turn increase in the demand for cardiac interventional procedures, thereby boosting the demand for vascular closure devices.

Moreover, the well-established patient care system along with awareness among patients and caregivers regarding the importance of diagnostic and therapeutic interventional procedures is further expected to propel the North American vascular closure devices market growth.

The Asia-Pacific region is expected to witness a significant growth in the vascular closure devices market in the forecast period which can ascribed to the fact that there has been constant efforts in improving healthcare access to the population in the countries in the region and the improvement in disposable income which has further been instrumental in more people opting for healthcare services. All these factors are collectively expected to contribute in the increase in the number of people availing routine diagnostic and treatment services for various diseases such as cardiovascular diseases wherein angiography procedures are majorly used. This is in turn, is expected to drive the demand for vascular closure devices in the region as these devices find application in the sealing of access point entry of the catheter, thereby boosting the growth of the vascular closure devices market in the forecast period.

Vascular Closure Devices Market Key Players:

Some of the key market players operating in the vascular closure devices market include Abbott, Teleflex Incorporated, Terumo Medical Corporation, Cardinal Health, Cardival Medical, Inc., Merit Medical Systems, Medtronic, Morris Innovative, TZ Medical, Vasorum Ltd, Tricol Biomedical, Vivasure Medical Ltd, Transluminal Technologies, W. L. Gore & Associates, Inc., Meril Life Sciences Pvt. Ltd, Gem srl others.

Recent Developmental Activities in Vascular Closure Devices Market:

In July 2022, Vivasure Medical announced the development of PerQseal® Blue, the new investigational product which is under development. PerQseal Blue is designed specifically for suture less and fully absorbable large-bore venous vessel closure to be used in the percutaneous cardiovascular procedures, such trans-catheter mitral valve repair or replacement (TMVR) and trans-catheter tricuspid valve repair or replacement (TTVR).

In March 2022, CyndRx LLC finalized the pivotal CE Mark trial with the strong clinical outcomes for their vascular closure device AbsorbaSeal(TM) for evaluating the safety and efficacy of this polymer-based device.

In January 2022, Haemonetics Corporation entered into a definitive agreement to acquire Cardiva Medical Inc., a privately owned manufacturer of vascular closure systems.

Key Takeaways from the Vascular Closure Devices Market Report Study

Market size analysis for current vascular closure devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the vascular closure devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global vascular closure devices market.

Various opportunities available for the other competitor in the vascular closure devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030?

Which is the top-performing regions and countries in the current vascular closure devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for vascular closure devices market growth in the coming future?

Target Audience who can be benefited from this Vascular Closure Devices Market Report Study

Vascular Closure Devices products providers

Research organizations and consulting companies

Vascular Closure Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in vascular closure devices

Various End-users who want to know more about the vascular closure devices market and latest technological developments in the vascular closure devices market.

Frequently Asked Questions for Vascular Closure Devices Market:

1. What is a Vascular Closure Device?

A vascular closure device are inserted at the end of a procedure with the aim to stop bleeding that occurs at the access point for the procedure in order to promote hemostasis and improve the ambulation time of patients.

2. What is the market for Global Vascular Closure Devices?

Global Vascular Closure Devices Market was valued at USD 1.11 billion in 2023, growing at a CAGR of 6.18% during the forecast period from 2024 to 2030 to reach USD 1.59 billion by 2030.

3. What are the drivers for Global Vascular Closure Devices Market?

Factors such as the growing prevalence of cardiovascular disorders, rising prevalence of risk factors associated with the cardiovascular diseases such as obesity and hypertension, increasing geriatric population, and the surge in the popularity of minimally invasive procedures, are expected to drive the vascular closure devices market.

4. What are the key players operating in Global Vascular Closure Devices Market?

Some of the key market players operating in the vascular closure devices market include Abbott, Teleflex Incorporated, Terumo Medical Corporation, Cardinal Health, Cardival Medical, Inc., Merit Medical Systems, Medtronic, Morris Innovative, TZ Medical, Vasorum Ltd, Tricol Biomedical, Vivasure Medical Ltd, Transluminal Technologies, W. L. Gore & Associates, Inc., Meril Life Sciences Pvt. Ltd, Gem srl, and others.

5. Which region has the highest share in Vascular Closure Devices market?

North America is expected to dominate the overall Vascular Closure Devices market during the forecast period, 2024 to 2030. North America is predicted to account for the dominant market share because of the high prevalence of cardiovascular diseases and associated risk factors, rising population of the elderly, high awareness among people regarding disease management and ability to afford such devices and among other factors in the region.

Table of Contents

1.Vascular Closure Devices Market Report Introduction

2. Vascular Closure Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
    • 3.2.1. Germany
    • 3.2.2. France
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. U.K.
  • 3.3. Japan

4. Vascular Closure Devices Market Key Factors Analysis

  • 4.1. Vascular Closure Devices Market Drivers
    • 4.1.1. Rising Number of Cardiovascular Diseases
    • 4.1.2. Increase in Prevalence of Risk Factors Associated with CVDs
    • 4.1.3. Growing Popularity of Minimally Invasive Procedures
    • 4.1.4. Surge in Product Innovation Activities
  • 4.2. Vascular Closure Devices Market Restraints and Challenges
    • 4.2.1. Complications Associated with Vascular Closure Devices
    • 4.2.2. Limitations of Vascular Closure Devices in Closing Large Bore Punctures
  • 4.3. Vascular Closure Devices Market Opportunities
    • 4.3.1. Development of Biosorbable Vascular Closure Devices

5. Vascular Closure Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Vascular Closure Devices Market

7. Vascular Closure Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. Active Approximators
      • 7.1.1.1. Suture-Based
      • 7.1.1.2. Clip-Based
      • 7.1.1.3. Assisted Compression Devices
    • 7.1.2. Passive Approximators
      • 7.1.2.1. Sealant or Gel-Based
      • 7.1.2.2. Biosorbable Plugs
    • 7.1.3. Others
  • 7.2. By Access Type
    • 7.2.1. Femoral
    • 7.2.2. Radial
  • 7.3. By End User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Vascular Closure Devices Market, by Product Type
      • 7.4.1.2. North America Vascular Closure Devices Market, by Access Type
      • 7.4.1.2. North America Vascular Closure Devices Market, by End User
      • 7.4.1.4. North America Vascular Closure Devices Market, by Country
      • 7.4.1.1.1. United States
      • 7.4.1.1.2. Canada
      • 7.4.1.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Vascular Closure Devices Market, by Product Type
      • 7.4.2.2. Europe Vascular Closure Devices Market, by Access Type
      • 7.4.2.3. Europe Vascular Closure Devices Market, by End User
      • 7.4.2.4. Europe Vascular Closure Devices Market, by Country
      • 7.4.2.2.1. France
      • 7.4.2.2.2. Germany
      • 7.4.2.2.3. United Kingdom
      • 7.4.2.2.4. Italy
      • 7.4.2.2.5. Spain
      • 7.4.2.2.6. Russia
      • 7.4.2.2.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Vascular Closure Devices Market, by Product Type
      • 7.4.3.2. Asia-Pacific Vascular Closure Devices Market, by Access Type
      • 7.4.3.3. Asia-Pacific Vascular Closure Devices Market, by End User
      • 7.4.3.4. Asia-Pacific Vascular Closure Devices Market, by Country
      • 7.4.3.4.1. China
      • 7.4.3.4.2. Japan
      • 7.4.3.4.3. India
      • 7.4.3.4.4. Australia
      • 7.4.3.4.5. South Korea
      • 7.4.3.4.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. RoW Vascular Closure Devices Market, by Product Type
      • 7.4.4.2. RoW Vascular Closure Devices Market, by Access Type
      • 7.4.4.3. RoW Vascular Closure Devices Market, by End User
      • 7.4.4.4. RoW Vascular Closure Devices Market, by Country
      • 7.4.4.3.1. Middle East
      • 7.4.4.3.2. Africa
      • 7.4.4.3.3. South America

8. Vascular Closure Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Vascular Closure Devices Market Company and Product Profiles

  • 9.1. Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Teleflex Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Terumo Medical Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Medtronic
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Cardinal Health
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Cardival Medical, Inc
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Merit Medical systems
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Morris Innovative
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. TZ Medical
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Vasorum Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Tricol Biomedical
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Vivasure Medical Ltd.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Transluminal Technologies
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. W. L. Gore & Associates, Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Meril Life Sciences Pvt. Ltd.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Gem srl
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy

10. Project Approach

  • 10.1. Secondary Sources
  • 10.2. Primary Sources
  • 10.3. Data Triangulation
  • 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight